Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
about
The cerebellum and migrainePregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels.Translational imaging studies of cortical spreading depression in experimental models for migraine aura.Familial hemiplegic migraine.Pain perception and laser evoked potentials during menstrual cycle in migraine.Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine.Clinical pharmacology of topiramate in migraine prevention.Spreading depression transiently disrupts myelin via interferon-gamma signaling.Trigger factors in primary headaches subtypes: a cross-sectional study from a tertiary centre in Greece.Cortical excitation and inhibition following focal traumatic brain injury.Topiramate for migraine prevention.Paradoxical air microembolism induces cerebral bioelectrical abnormalities and occasionally headache in patent foramen ovale patients with migraine.Migraine preventive therapy: selection of appropriate patients and general principles of management.Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.Psychological risk factors in headacheInsulin-like growth factor-1 lowers spreading depression susceptibility and reduces oxidative stress.Cortical spreading depression and estrogen.Migraine excitability.Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine.Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability.CADASIL and migraine: A narrative review.Migraine is a neuronal disease.Vision and migraine.Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.Migraine, stroke and epilepsy: underlying and interrelated causes, diagnosis and treatment.The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate.Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine.Failure of feedback as a putative common mechanism of spreading depolarizations in migraine and stroke.Effects of rizatriptan on the contingent negative variation in healthy women.Headache Following Occipital Brain Lesion: A Case of Migraine Triggered by Occipital Spikes?Orbitofrontal disinhibition of pain in migraine with aura: an interictal EEG-mapping study.Topiramate is likely to act outside of the trigeminocervical complex.The effect of viewing distance on responses to the pattern glare test.Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain
P2860
Q24628942-5EDCB664-BE11-4B98-95A9-1D04092C216AQ30498941-1C4D1A12-4785-4D19-A7D7-F62206E6CC39Q31154455-AD63911D-6E50-49AD-B948-4E100C4EAAD6Q33280531-2F3B4C9F-97AC-4084-86D3-B66EDD99FB34Q33504671-EFCFF2CD-46DB-46C8-B928-EA30EA60A71CQ33535616-37DEBF48-D411-4FEB-880B-1658F78076A6Q34200361-17BAA582-AD2A-4CD1-B14D-BBBE64B6A6A6Q35071478-16E093F1-EF2A-4F5C-A5D2-3941D3902C18Q35760687-B3740B32-E122-4E97-9DBE-8EDA7C4E0BB2Q36239278-B5E353A1-F13A-47A1-8EF8-2EF6DCF6A88BQ36407219-ED12BBBB-D45C-4C5A-B61B-6CBBEDFFE413Q36519761-88807B45-57CB-4339-97C9-8E6E44BBE024Q36558665-52A8E20B-90DD-4554-954F-54032A119F88Q36598107-2CC33DB6-D70B-40D2-8B9C-933B089AEAB6Q36692356-60D41B68-866A-4722-837A-E26C9E2F0231Q36774399-CEA58C3E-D9D3-43A6-9CAB-1552FB90F7C1Q36938678-EC9FE7C2-1010-44D0-931F-F6F66886CD3EQ37012133-08077E47-9729-46DA-BDE2-0846BF52F7CEQ37100356-D4B1F3CE-2BBC-45C0-A28E-51FFD1676E1DQ37165739-66BFD73C-9091-42C7-A809-C44171C752CAQ37805397-81DD4D51-525C-4797-B522-ED173055C7CAQ37821333-34DF6E37-84C9-4E4D-B44C-16A0922D0D19Q38372873-E07BD3BC-C3A6-4561-B282-66900D439E8BQ42595917-2C6AD68A-C24C-48B1-8127-03E0E884F293Q44131473-8EACDF57-08A1-425E-B9D1-98ACECE49C0DQ45986094-180BBE3C-9B5A-4639-BEED-F864AFBB8967Q46389732-F0096D38-9343-4D2B-895A-08C671002136Q46501947-62FBF527-0454-40E8-A0C3-387BA44B3020Q46567105-ECBF35F8-949C-4C63-A3EC-2BEB375DD629Q48015966-7EA8C407-6001-46F9-9C4E-9F8D2B6934AEQ48113685-9DF865E4-CFED-4F34-945E-C24E10F2E89EQ48213282-26BA0C76-B103-4547-892C-35BDF55086E7Q50317058-55B6D10A-0A59-4FB4-ADBC-29F0A5E7BE47Q50453193-5465738A-07FB-4D62-A32A-2F6E57F39B35Q58781288-409F9DA0-2342-4F28-AA22-D973CA829737
P2860
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
@ast
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
@en
type
label
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
@ast
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
@en
prefLabel
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
@ast
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
@en
P2860
P1433
P1476
Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.
@en
P2093
K Michael Welch
P2860
P304
P356
10.1111/J.1526-4610.2005.4501008.X
P478
45 Suppl 1
P577
2005-04-01T00:00:00Z